Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMFA04010502 ent-14-J4-NeuroP (Z)-6-((1R,5R)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010442 ent-14-epi-14-A4-NeuroP (Z)-6-((1S,2S)-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010226 ent-14-epi-14-D4t-NeuroP (Z)-6-((1S,2R,5R)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010223 ent-14-epi-14-D4t-NeuroP (Z)-6-((1R,2S,5R)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010354 ent-14-epi-14-E4t-NeuroP (Z)-6-((1S,2R,3S)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010351 ent-14-epi-14-E4t-NeuroP (Z)-6-((1R,2S,3S)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010098 ent-14-epi-14-F4t-NeuroP (Z)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010095 ent-14-epi-14-F4t-NeuroP (Z)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010506 ent-14-epi-14-J4-NeuroP (Z)-6-((1R,5R)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010428 ent-16-epi-13-A4-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010204 ent-16-epi-13-D4c-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2R,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010205 ent-16-epi-13-D4t-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010332 ent-16-epi-13-E4c-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010333 ent-16-epi-13-E4t-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010076 ent-16-epi-13-F4c-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010077 ent-16-epi-13-F4t-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010492 ent-16-epi-13-J4-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,5R)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010446 ent-17-A4-NeuroP (4Z,7Z)-9-((1S,2S)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010238 ent-17-D4c-NeuroP (4Z,7Z)-9-((1S,2R,5R)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010235 ent-17-D4t-NeuroP (4Z,7Z)-9-((1R,2S,5R)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010366 ent-17-E4c-NeuroP (4Z,7Z)-9-((1S,2R,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010363 ent-17-E4t-NeuroP (4Z,7Z)-9-((1R,2S,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010110 ent-17-F4c-NeuroP (4Z,7Z)-9-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010107 ent-17-F4t-NeuroP (4Z,7Z)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010510 ent-17-J4-NeuroP (4Z,7Z)-9-((1R,5R)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010450 ent-17-epi-17-A4-NeuroP (4Z,7Z)-9-((1S,2S)-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010242 ent-17-epi-17-D4t-NeuroP (4Z,7Z)-9-((1S,2R,5R)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010239 ent-17-epi-17-D4t-NeuroP (4Z,7Z)-9-((1R,2S,5R)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010367 ent-17-epi-17-E4t-NeuroP (4Z,7Z)-9-((1R,2S,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010370 ent-17-epi-17-E4t-NeuroP (4Z,7Z)-9-((1S,2R,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010114 ent-17-epi-17-F4t-NeuroP (4Z,7Z)-9-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010111 ent-17-epi-17-F4t-NeuroP (4Z,7Z)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010514 ent-17-epi-17-J4-NeuroP (4Z,7Z)-9-((1R,5R)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010454 ent-20-A4-NeuroP (4Z,7Z,10Z)-12-((1S,2S)-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010254 ent-20-D4c-NeuroP (4Z,7Z,10Z)-12-((1S,2R,5R)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010251 ent-20-D4t-NeuroP (4Z,7Z,10Z)-12-((1R,2S,5R)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010382 ent-20-E4c-NeuroP (4Z,7Z,10Z)-12-((1S,2R,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010379 ent-20-E4t-NeuroP (4Z,7Z,10Z)-12-((1R,2S,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010126 ent-20-F4c-NeuroP (4Z,7Z,10Z)-12-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010123 ent-20-F4t-NeuroP (4Z,7Z,10Z)-12-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010518 ent-20-J4-NeuroP (4Z,7Z,10Z)-12-((1R,5R)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010458 ent-20-epi-20-A4-NeuroP (4Z,7Z,10Z)-12-((1S,2S)-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010255 ent-20-epi-20-D4t-NeuroP (4Z,7Z,10Z)-12-((1R,2S,5R)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010258 ent-20-epi-20-D4t-NeuroP (4Z,7Z,10Z)-12-((1S,2R,5R)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010386 ent-20-epi-20-E4t-NeuroP (4Z,7Z,10Z)-12-((1S,2R,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010383 ent-20-epi-20-E4t-NeuroP (4Z,7Z,10Z)-12-((1R,2S,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010130 ent-20-epi-20-F4t-NeuroP (4Z,7Z,10Z)-12-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010127 ent-20-epi-20-F4t-NeuroP (4Z,7Z,10Z)-12-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010522 ent-20-epi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1R,5R)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010424 ent-4,11-diepi-11-A4-NeuroP 3-((1R,2S)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4